Skip to Main Content

Author Details

Irene Casanova-Salas
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
2012
19
11
PMIDPaper TitleJournal TitlePublished Year
35181943Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology.Magn Reson Med2022
35820087Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies.JCO Precis Oncol2022
33176972Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.Eur Urol2021
33422353Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.Eur Urol2021
31092557The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.J Cell Biol2019
31685984Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis.Nat Cell Biol2019
29617673Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells.Cell Rep2018
28545426Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.BMC Cancer2017
25969992MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.PLoS One2015
26362197Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.BMC Cancer2015
25920992External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.Actas Urol Esp2015
25906745ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.Oncotarget2015
25948797[Update on the diagnosis of PCa in urine. The current role of urine markers].Arch Esp Urol2015
24169211Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.Actas Urol Esp2014
25204806Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.Eur J Cancer2014
24914846[New biomarkers to optimize the selection and follow up of patients with prostate cancer on active surveillance].Arch Esp Urol2014
24518785Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.J Urol2014
23793762[Non-invasive diagnosis of prostate cancer: serum and urine markers].Arch Esp Urol2013
22855165miRNAs as biomarkers in prostate cancer.Clin Transl Oncol2012
  • 1 - 19 of 19

Recommended Authors

Christianne Hoey
Evaluative Clinical Sciences, Sunnybrook Research Institute
Career Start Year 2017
Number of shared co-authors 1
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 1
Nicholas Erho
GenomeDx Biosciences Inc.
Career Start Year 2012
Number of shared co-authors 6
Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
Career Start Year 2011
Number of shared co-authors 2
Agnes Marije Hoogland
Erasmus Medical Center
Career Start Year 2011
Number of shared co-authors 1
Tamara Jamaspishvili
Queen's University
Career Start Year 2010
Number of shared co-authors 1
Mandeep Takhar
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 3
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 5
Shancheng Ren
Shanghai Changzheng Hospital
Career Start Year 2007
Number of shared co-authors 1
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 5
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 2
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 4
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 2
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 9
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 9
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 3
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 6
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 2
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 1
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 6
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 4
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 3
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 6
Penny Flohr
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 9
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 12
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 8
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 2
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 16
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1987
Number of shared co-authors 2
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 7

Collaborators

Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 4
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 4
Alejandro Athie
Vall d'Hebron Institute of Oncology (VHIO)
Co-authored papers 2
Susana Miranda
The Institute of Cancer Research
Co-authored papers 1
Henrik Molina
Co-authored papers 1
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers 1
Patricia S Steeg
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 1
Marzia Del Re
University of Pisa
Co-authored papers 1
Edwin M Posadas
Cedars-Sinai Medical Center
Co-authored papers 1
Adam Sharp
The Institute for Cancer Research
Co-authored papers 1
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 1
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Co-authored papers 1
Adam G Sowalsky
National Cancer Institute
Co-authored papers 1
Wei Yuan
The Institute for Cancer Research
Co-authored papers 1
David T Miyamoto
Massachusetts General Hospital
Co-authored papers 1
Alexandra C Newton
Co-authored papers 1
Alexander W Wyatt
University of British Columbia
Co-authored papers 1
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Alec Paschalis
The Institute for Cancer Research
Co-authored papers 1
Nasser K Altorki
New York-Presbyterian Hospital
Co-authored papers 1
David J Pisapia
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Co-authored papers 1
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 1
Jeffrey S Ross
Foundation Medicine
Co-authored papers 1
Release 1.2